PMC - PharMerica Corporation

NYSE - NYSE Delayed Price. Currency in USD
29.25
+0.05 (+0.17%)
At close: 4:02PM EST
Stock chart is not supported by your current browser
Previous Close29.20
Open29.20
Bid0.00 x 0
Ask0.00 x 0
Day's Range29.20 - 29.27
52 Week Range0.08 - 29.50
Volume1,371,608
Avg. Volume265,319
Market Cap910.266M
Beta0.63
PE Ratio (TTM)48.03
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • GuruFocus.com3 days ago

    Pharmerica Corp (PMC) CEO Gregory S Weishar Sold $15.2 million of Shares

    CEO of Pharmerica Corp (NYSE:PMC) Gregory S Weishar sold 521,089 shares of PMC on 12/07/2017 at an average price of $29.25 a share.

  • American City Business Journals7 days ago

    Walgreens, KKR complete $1.4 billion acquisition of PharMerica

    A joint venture between KKR & Co. L.P. and Walgreens Boots Alliance Inc. has completed its acquisition of Louisville-based institutional pharmacy provider PharMerica Corp. in a $1.4 billion deal. PharMerica (PMC) shareholders will receive $29.25 per share for their stock in the company, which will cease trading on the New York Stock Exchange tomorrow. PharMerica announced the merger in August and said the deal would be completed in early 2018.

  • PharMerica Corp. breached its 50 day moving average in a Bullish Manner : PMC-US : November 17, 2017
    Capital Cube27 days ago

    PharMerica Corp. breached its 50 day moving average in a Bullish Manner : PMC-US : November 17, 2017

    Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for PharMerica Corp.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bullish 50 ... Read more (Read more...)

  • Why PharMerica Corporation (PMC) Delivered An Inferior ROE Compared To The Industry
    Simply Wall St.last month

    Why PharMerica Corporation (PMC) Delivered An Inferior ROE Compared To The Industry

    PharMerica Corporation (NYSE:PMC) delivered a less impressive 4.28% ROE over the past year, compared to the 14.78% return generated by its industry. Though PMC’s recent performance is underwhelming, it isRead More...

  • Associated Presslast month

    PharMerica posts 3Q profit

    On a per-share basis, the Louisville, Kentucky-based company said it had profit of 10 cents. Earnings, adjusted for amortization costs and costs related to mergers and acquisitions, were 46 cents per share. ...

  • American City Business Journalslast month

    PharMerica shareholders vote on $1.4 billion acquisition

    Shareholders of Louisville-based PharMerica Corp. voted overwhelmingly to approve the company's $1.4 billion acquisition by KKR & Co. L.P. and Walgreens Boots Alliance. More than 99 percent of the votes cast, representing about 79 percent of PharMerica's common shares as of Sept. 28 (the record date for the special meeting), were in favor of adopting the merger agreement, according to a news release. The deal calls for PharMerica to be acquired by a new company controlled by KKR, a New York City-based private-equity firm, with Deerfield, Ill.-based Walgreens Boots Alliance Inc. (WBA) as a minority investor.

  • PharMerica Corp. breached its 50 day moving average in a Bullish Manner : PMC-US : November 7, 2017
    Capital Cubelast month

    PharMerica Corp. breached its 50 day moving average in a Bullish Manner : PMC-US : November 7, 2017

    Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for PharMerica Corp.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bullish 50 ... Read more (Read more...)

  • Capital Cubelast month

    PharMerica Corp. – Value Analysis (NYSE:PMC) : October 30, 2017

    Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives PharMerica Corp. a score of 47. Our analysis is based on comparing PharMerica Corp. with the following peers – Walgreens Boots Alliance Inc, CVS Health Corporation, BioScrip, Inc., Rite Aid Corporation, Kindred Healthcare, Inc., AmerisourceBergen Corporation, SunLink Health Systems, Inc. and Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited ... Read more (Read more...)

  • PharMerica Corp. breached its 50 day moving average in a Bearish Manner : PMC-US : October 27, 2017
    Capital Cube2 months ago

    PharMerica Corp. breached its 50 day moving average in a Bearish Manner : PMC-US : October 27, 2017

    Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for PharMerica Corp.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average Bullish 50 ... Read more (Read more...)

  • American City Business Journals2 months ago

    PharMerica details millions in golden parachute money for executives

    PharMerica Corp. executives could receive millions from the company if they are terminated after the completion of its planned $1.4 billion acquisition. The so-called "golden parachute compensation" for the company's named executives could total about $27.7 million, according to a filing with the U.S. Securities and Exchange Commission. PharMerica has agreed to be acquired by a new company, Phoenix Parent Holdings Inc., which is controlled by New York-based KKR & Co. L.P., with Deerfield, Ill.-based Walgreens Boots Alliance Inc. (WBA) as a minority investor.

  • PharMerica Corp. :PMC-US: Earnings Analysis: Q2, 2017 By the Numbers : September 29, 2017
    Capital Cube2 months ago

    PharMerica Corp. :PMC-US: Earnings Analysis: Q2, 2017 By the Numbers : September 29, 2017

    Categories: Yahoo FinanceGet free summary analysis PharMerica Corp. reports financial results for the quarter ended June 30, 2017. Highlights Summary numbers: Revenues of USD 592 million, Net Earnings of USD 4.70 million. Gross margins narrowed from 14.16% to 13.46% compared to the same period last year, operating (EBITDA) margins now 5.84% from 6.12%. Change in operating cash ... Read more (Read more...)

  • Moody's3 months ago

    PharMerica Corporation -- Moody's assigns B2 CFR to PharMerica Corporation; outlook stable

    Rating Action: Moody's assigns B2 CFR to PharMerica Corporation; outlook stable. Global Credit Research- 12 Sep 2017. New York, September 12, 2017-- Moody's Investors Service today assigned a B2 Corporate ...

  • TheStreet.com3 months ago

    Private Briefing: KKR's Healthcare Deal Spree

    The healthcare team led by James Momtazee has been very busy, with deals for PharMerica, American Medical Response and Covenant Surgical Partners, among others.

  • Envision Healthcare Hurt by High Debt, Increasing Expenses
    Zacks4 months ago

    Envision Healthcare Hurt by High Debt, Increasing Expenses

    Envision Healthcare's (EVHC) increasing debt and expenses continue to hurt. Further guidance cut by the company is concerning.

  • PharMerica Corp.: Strong price momentum but will it sustain?
    Capital Cube4 months ago

    PharMerica Corp.: Strong price momentum but will it sustain?

    Categories: Yahoo FinancePharMerica Corp. relative valuation is OVERVALUED and it has a fundamental analysis score of 47. Our analysis is based on comparing PharMerica Corp. with the following peers – Walgreens Boots Alliance Inc, CVS Health Corporation, BioScrip, Inc., Rite Aid Corporation, Kindred Healthcare, Inc., SunLink Health Systems, Inc., AmerisourceBergen Corporation and Guangzhou Baiyunshan Pharmaceutical Holdings Company ... Read more (Read more...)

  • Healthcare Q2 Earnings to Watch Out on Aug 4: WCG & PMC
    Zacks4 months ago

    Healthcare Q2 Earnings to Watch Out on Aug 4: WCG & PMC

    Earnings in healthcare industry to be driven by acquisitions, branching out into ancillary businesses, new product and services, partly offset by increasing expenses.

  • PharMerica Corp. breached its 50 day moving average in a Bullish Manner : PMC-US : August 3, 2017
    Capital Cube4 months ago

    PharMerica Corp. breached its 50 day moving average in a Bullish Manner : PMC-US : August 3, 2017

    Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for PharMerica Corp.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bullish 50 ... Read more (Read more...)

  • Associated Press4 months ago

    PharMerica meets 2Q profit forecasts

    The Louisville, Kentucky-based company said it had profit of 15 cents per share. Earnings, adjusted for amortization costs and costs related to mergers and acquisitions, came to 47 cents per share. The ...

  • InvestorPlace4 months ago

    PharMerica Corporation (PMC) Shares Surge on Walgreens, Going Private

    PharMerica Corporation (NYSE:PMC) shares are skyrocketing as the company announced its plans to go private. The pharmaceutical company will be acquired by KKR & Co. L.P. Unit (NYSE:KKR) for $909.4 million in cash. Walgreens Boots Alliance (NASDAQ:WBA) is a minority investor in the deal. KKR will assume about $490 million of PharMerica’s debt.

  • Why PharMerica Stock Is Soaring Today
    Motley Fool4 months ago

    Why PharMerica Stock Is Soaring Today

    The company is being acquired by KKR and Walgreens Boots Alliance.

  • TheStreet.com4 months ago

    Walgreens Takes Piece of PharMerica, Quest to Dominate Healthcare Continues

    The deal is worth $1.4 billion and PharMerica's board has already given it the green light.